Inotiv_Logo_CMYK.png
Inotiv, Inc. Announces Additional Site Consolidation Plan in the U.S., Intent to Consult with Employee Representatives for a Proposed Consolidation of Certain European and U.K. Sites, and Update on Site Optimization Plans in Process
29 nov. 2022 16h55 HE | Inotiv, Inc.
WEST LAFAYETTE, Ind., Nov. 29, 2022 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ: NOTV) (the “Company”, “We”, “Our” or “Inotiv”), a leading contract research organization specializing in nonclinical and...
Inotiv_Logo_CMYK.png
Inotiv, Inc. Announces Site Closures and Consolidation Plans
13 juin 2022 20h10 HE | Inotiv, Inc.
WEST LAFAYETTE, Ind., June 13, 2022 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ: NOTV) (the “Company”, “We”, “Our” or “Inotiv”), a leading contract research organization specializing in nonclinical and...
Inotiv_Logo_CMYK.png
Inotiv, Inc. Announces Expansion of Non-Human Primate Facilities and Services with Acquisition of Orient BioResource Center, Inc.
27 janv. 2022 12h00 HE | Inotiv, Inc.
WEST LAFAYETTE, Ind., Jan. 27, 2022 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ: NOTV) (the “Company”, “We”, “Our” or “Inotiv”), a leading contract research organization specializing in nonclinical and...
Inotiv_Logo_CMYK.png
Inotiv, Inc. Announces the Acquisition of the Rabbit Breeding and Supply Business of Robinson Services Inc. (“RSI”)
06 janv. 2022 08h33 HE | Inotiv, Inc.
WEST LAFAYETTE, Ind., Jan. 06, 2022 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ: NOTV) (the “Company”, “We”, “Our” or “Inotiv”), a leading contract research organization specializing in nonclinical and...
Inotiv_Logo_CMYK.png
Inotiv, Inc. Completes Purchase of Envigo
05 nov. 2021 13h33 HE | Inotiv, Inc.
WEST LAFAYETTE, Ind. and INDIANAPOLIS, Nov. 05, 2021 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ:NOTV) (or “Inotiv”), a leading contract research organization (CRO) specializing in nonclinical and...
Inotiv_Logo_CMYK.png
Inotiv, Inc. and Envigo Propose to Join Forces to Enhance Research and Drug Discovery Solutions
21 sept. 2021 09h00 HE | Inotiv, Inc.
-- Expected to establish a leading global provider of a full spectrum of pre-clinical solutions -- -- Expected to be immediately accretive to Inotiv earnings and margins before synergies -- --...